{"transactions":[{"id":4636930,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Common Stock","published_at":"2026-10-07T20:02:52.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":296,"price":4.39,"value":1299.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person."}],"balance_after":162805,"source":{"system":"sec-edgar","filing":"0001628280-26-065326","document":"wk-form4_1791403369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1981787/000162828026065326/wk-form4_1791403369.xml","form_type":"4"}},{"id":4636929,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-10-07T20:02:44.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":325,"price":4.39,"value":1426.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person."}],"balance_after":127994,"source":{"system":"sec-edgar","filing":"0001628280-26-065325","document":"wk-form4_1791403362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026065325/wk-form4_1791403362.xml","form_type":"4"}},{"id":4636928,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-10-07T20:02:37.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":316,"price":4.39,"value":1387.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person."}],"balance_after":123794,"source":{"system":"sec-edgar","filing":"0001628280-26-065324","document":"wk-form4_1791403354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000162828026065324/wk-form4_1791403354.xml","form_type":"4"}},{"id":4636927,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-10-07T20:02:29.000Z","date":"2026-10-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2693,"price":4.38,"value":11795.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted."}],"balance_after":1074990,"source":{"system":"sec-edgar","filing":"0001628280-26-065323","document":"wk-form4_1791403347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026065323/wk-form4_1791403347.xml","form_type":"4"}},{"id":714298,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:01:13.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":14650,"price":4.46,"value":65339.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted."}],"balance_after":261107,"source":{"system":"sec-edgar","filing":"0001628280-26-047217","document":"wk-form4_1783368070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026047217/wk-form4_1783368070.xml","form_type":"4"}},{"id":720995,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:04:47.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":3990,"price":3.87,"value":15441.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":1077683,"source":{"system":"sec-edgar","filing":"0001628280-26-046519","document":"wk-form4_1782936285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026046519/wk-form4_1782936285.xml","form_type":"4"}},{"id":720994,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:03:32.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2100,"price":4.38,"value":9198.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":1023826,"source":{"system":"sec-edgar","filing":"0001628280-26-046511","document":"wk-form5_1782936210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026046511/wk-form5_1782936210.xml","form_type":"5"}},{"id":720993,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:03:32.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":2848,"price":4.23,"value":12047.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":596726,"source":{"system":"sec-edgar","filing":"0001628280-26-046511","document":"wk-form5_1782936210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026046511/wk-form5_1782936210.xml","form_type":"5"}},{"id":720992,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:03:32.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":3530,"price":4.26,"value":15037.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":513207,"source":{"system":"sec-edgar","filing":"0001628280-26-046511","document":"wk-form5_1782936210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026046511/wk-form5_1782936210.xml","form_type":"5"}},{"id":721495,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:02:47.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":561,"price":3.87,"value":2171.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":128319,"source":{"system":"sec-edgar","filing":"0001628280-26-046507","document":"wk-form4_1782936164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046507/wk-form4_1782936164.xml","form_type":"4"}},{"id":721494,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":449,"price":4.38,"value":1966.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":131758,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":721493,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":930,"price":4.23,"value":3933.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":71309,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":721492,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":999,"price":4.26,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":35404,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":721491,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":279,"price":4.69,"value":1308.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":27530,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":723650,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34724,"kind":"person","name":"Marshall Richard Henry","position":1,"cik":"0002142265","reported_name":"Marshall Richard Henry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-29T20:33:30.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":253000,"derivative":{"exercise_price":4.74,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001628280-26-046015","document":"wk-form4_1782765207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026046015/wk-form4_1782765207.xml","form_type":"4"}},{"id":723649,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34724,"kind":"person","name":"Marshall Richard Henry","position":1,"cik":"0002142265","reported_name":"Marshall Richard Henry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T20:33:30.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001628280-26-046015","document":"wk-form4_1782765207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026046015/wk-form4_1782765207.xml","form_type":"4"}},{"id":772500,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T20:08:09.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":543,"price":2.67,"value":1449.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person."}],"balance_after":125101,"source":{"system":"sec-edgar","filing":"0001628280-26-036427","document":"wk-form4_1779221287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026036427/wk-form4_1779221287.xml","form_type":"4"}},{"id":774884,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:42:42.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":2.53,"value":151800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":147555,"source":{"system":"sec-edgar","filing":"0001628280-26-035996","document":"wk-form4_1779136958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035996/wk-form4_1779136958.xml","form_type":"4"}},{"id":774789,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-05-18T20:42:30.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":39682,"price":2.59,"value":102776.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 39,682 shares at a weighted average price of $2.59, with the Reporting Person's sales of 4,358 shares of common stock at a price per share of $4.13 on March 11, 2026 and of 15,944 shares of common stock at a price per share of $3.85. The prior sales represented shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person, and did not represent discretionary sales by the Reporting Person. The Reporting Person paid $27,573.70 to the Issuer, representing the full amount of profit realized in connection with the short-swing transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":1065215,"source":{"system":"sec-edgar","filing":"0001628280-26-035994","document":"wk-form4_1779136946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026035994/wk-form4_1779136946.xml","form_type":"4"}},{"id":774241,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:42:24.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":7100,"price":2.43,"value":17253.0,"ownership":{"direct":true},"balance_after":275757,"source":{"system":"sec-edgar","filing":"0001628280-26-035992","document":"wk-form4_1779136942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026035992/wk-form4_1779136942.xml","form_type":"4"}},{"id":774811,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T16:42:35.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":2.5,"value":500000.0,"ownership":{"direct":false,"nature":"By Skyview Investments LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member."}],"balance_after":399698,"source":{"system":"sec-edgar","filing":"0001628280-26-035995","document":"wk-form4_1779136952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026035995/wk-form4_1779136952.xml","form_type":"4"}},{"id":774810,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T16:42:35.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":410000,"price":2.5,"value":1025000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":1240722,"source":{"system":"sec-edgar","filing":"0001628280-26-035995","document":"wk-form4_1779136952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026035995/wk-form4_1779136952.xml","form_type":"4"}},{"id":775160,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46473,"kind":"person","name":"Gordon Gary B.","position":1,"cik":"0001811354","reported_name":"Gordon Gary B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T16:42:18.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.46,"value":24600.0,"ownership":{"direct":true},"balance_after":72510,"source":{"system":"sec-edgar","filing":"0001628280-26-035991","document":"wk-form4_1779136936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811354/000162828026035991/wk-form4_1779136936.xml","form_type":"4"}},{"id":777536,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":47004,"kind":"person","name":"HICKS KERRY R","position":1,"cik":"0001110473","reported_name":"HICKS KERRY R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T20:39:34.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":56403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":145625,"derivative":{"exercise_price":2.52,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":56403},"source":{"system":"sec-edgar","filing":"0001628280-26-035669","document":"wk-form4_1778877571.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1110473/000162828026035669/wk-form4_1778877571.xml","form_type":"4"}},{"id":777535,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":47004,"kind":"person","name":"HICKS KERRY R","position":1,"cik":"0001110473","reported_name":"HICKS KERRY R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:34.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":28201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":542790,"source":{"system":"sec-edgar","filing":"0001628280-26-035669","document":"wk-form4_1778877571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110473/000162828026035669/wk-form4_1778877571.xml","form_type":"4"}},{"id":776968,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T20:39:26.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":75204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":276149,"derivative":{"exercise_price":2.52,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":75204},"source":{"system":"sec-edgar","filing":"0001628280-26-035667","document":"wk-form4_1778877563.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035667/wk-form4_1778877563.xml","form_type":"4"}},{"id":776967,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:26.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":34226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of restricted stock units (the \"Retainer RSU Award\") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":87555,"source":{"system":"sec-edgar","filing":"0001628280-26-035667","document":"wk-form4_1778877563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035667/wk-form4_1778877563.xml","form_type":"4"}},{"id":776966,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:26.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":37602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":53329,"source":{"system":"sec-edgar","filing":"0001628280-26-035667","document":"wk-form4_1778877563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035667/wk-form4_1778877563.xml","form_type":"4"}},{"id":777146,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46473,"kind":"person","name":"Gordon Gary B.","position":1,"cik":"0001811354","reported_name":"Gordon Gary B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T20:39:20.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":56403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":112653,"derivative":{"exercise_price":2.52,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":56403},"source":{"system":"sec-edgar","filing":"0001628280-26-035665","document":"wk-form4_1778877558.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811354/000162828026035665/wk-form4_1778877558.xml","form_type":"4"}},{"id":777145,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46473,"kind":"person","name":"Gordon Gary B.","position":1,"cik":"0001811354","reported_name":"Gordon Gary B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:20.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":24553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of restricted stock units (the \"Retainer RSU Award\") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":62510,"source":{"system":"sec-edgar","filing":"0001628280-26-035665","document":"wk-form4_1778877558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811354/000162828026035665/wk-form4_1778877558.xml","form_type":"4"}},{"id":777144,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46473,"kind":"person","name":"Gordon Gary B.","position":1,"cik":"0001811354","reported_name":"Gordon Gary B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:20.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":28201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":37957,"source":{"system":"sec-edgar","filing":"0001628280-26-035665","document":"wk-form4_1778877558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811354/000162828026035665/wk-form4_1778877558.xml","form_type":"4"}},{"id":776868,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T20:39:15.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":56403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":121403,"derivative":{"exercise_price":2.52,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":56403},"source":{"system":"sec-edgar","filing":"0001628280-26-035664","document":"wk-form4_1778877552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000162828026035664/wk-form4_1778877552.xml","form_type":"4"}},{"id":776867,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:15.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":23065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of restricted stock units (the \"Retainer RSU Award\") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1323210,"source":{"system":"sec-edgar","filing":"0001628280-26-035664","document":"wk-form4_1778877552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000162828026035664/wk-form4_1778877552.xml","form_type":"4"}},{"id":776866,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:15.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":28201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1300145,"source":{"system":"sec-edgar","filing":"0001628280-26-035664","document":"wk-form4_1778877552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000162828026035664/wk-form4_1778877552.xml","form_type":"4"}},{"id":777333,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46962,"kind":"person","name":"Valle William","position":1,"cik":"0002018493","reported_name":"Valle William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T20:39:09.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":56403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":112653,"derivative":{"exercise_price":2.52,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":56403},"source":{"system":"sec-edgar","filing":"0001628280-26-035663","document":"wk-form4_1778877546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2018493/000162828026035663/wk-form4_1778877546.xml","form_type":"4"}},{"id":777332,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46962,"kind":"person","name":"Valle William","position":1,"cik":"0002018493","reported_name":"Valle William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:09.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":24553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of restricted stock units (the \"Retainer RSU Award\") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":83241,"source":{"system":"sec-edgar","filing":"0001628280-26-035663","document":"wk-form4_1778877546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2018493/000162828026035663/wk-form4_1778877546.xml","form_type":"4"}},{"id":777331,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46962,"kind":"person","name":"Valle William","position":1,"cik":"0002018493","reported_name":"Valle William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:09.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":28201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":58688,"source":{"system":"sec-edgar","filing":"0001628280-26-035663","document":"wk-form4_1778877546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018493/000162828026035663/wk-form4_1778877546.xml","form_type":"4"}},{"id":776931,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T20:39:01.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":47003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":139540,"derivative":{"exercise_price":2.52,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":47003},"source":{"system":"sec-edgar","filing":"0001628280-26-035662","document":"wk-form4_1778877538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026035662/wk-form4_1778877538.xml","form_type":"4"}},{"id":776930,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:01.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":20089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of restricted stock units (the \"Retainer RSU Award\") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":830722,"source":{"system":"sec-edgar","filing":"0001628280-26-035662","document":"wk-form4_1778877538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026035662/wk-form4_1778877538.xml","form_type":"4"}},{"id":776929,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:01.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":23501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":810633,"source":{"system":"sec-edgar","filing":"0001628280-26-035662","document":"wk-form4_1778877538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026035662/wk-form4_1778877538.xml","form_type":"4"}},{"id":804246,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":51895,"kind":"person","name":"Frankenius Equity AB","position":1,"cik":"0001988262","reported_name":"Frankenius Equity AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-04-20T20:36:46.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":false,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents conversion price pursuant to an offer (the \"Offer\") the Company commenced on June 23, 2025, under which all holders of Preferred Stock could exchange their shares of Preferred Stock for Common Stock equal to the sum of the liquidation preference per share price of $10.00 and all accrued and unpaid dividends per share outstanding through August 10, 2027, divided by a $4.00 conversion price per share."},{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2025, all 230,000 shares of Preferred Stock held by the Reporting Person were converted into 759,000 shares of Common Stock pursuant to the Offer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 31, 2025, all 230,000 shares of Preferred Stock held by the Reporting Person were converted into 759,000 shares of Common Stock pursuant to the Offer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 31, 2025, all 230,000 shares of Preferred Stock held by the Reporting Person were converted into 759,000 shares of Common Stock pursuant to the Offer."}],"balance_after":0,"derivative":{"exercise_price":4,"underlying":"Common Stock","underlying_shares":759000},"source":{"system":"sec-edgar","filing":"0001628280-26-026014","document":"wk-form4_1776717403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026026014/wk-form4_1776717403.xml","form_type":"4"}},{"id":804245,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":51895,"kind":"person","name":"Frankenius Equity AB","position":1,"cik":"0001988262","reported_name":"Frankenius Equity AB","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T20:36:46.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":true,"shares":759000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares received upon conversion of the Series A Preferred Stock (the \"Preferred Stock\") reported in Table II."}],"balance_after":6989748,"source":{"system":"sec-edgar","filing":"0001628280-26-026014","document":"wk-form4_1776717403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026026014/wk-form4_1776717403.xml","form_type":"4"}},{"id":822693,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-04-01T20:09:16.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents conversion price pursuant to an offer (the \"Offer\") the Company commenced on June 23, 2025, under which all holders of Preferred Stock could exchange their shares of Preferred Stock for Common Stock equal to the sum of the liquidation preference per share price of $10.00 and all accrued and unpaid dividends per share outstanding through August 10, 2027, divided by a $4.00 conversion price per share."},{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer."}],"balance_after":0,"derivative":{"exercise_price":4,"underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001628280-26-022792","document":"wk-form4_1775074153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000162828026022792/wk-form4_1775074153.xml","form_type":"4"}},{"id":822692,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T20:09:16.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares received upon conversion of the Series A Preferred Stock (the \"Preferred Stock\") reported in Table II."}],"balance_after":1271944,"source":{"system":"sec-edgar","filing":"0001628280-26-022792","document":"wk-form4_1775074153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000162828026022792/wk-form4_1775074153.xml","form_type":"4"}},{"id":831844,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:50.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":579,"price":4.12,"value":2385.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":163415,"source":{"system":"sec-edgar","filing":"0001628280-26-020189","document":"wk-form4_1774038346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026020189/wk-form4_1774038346.xml","form_type":"4"}},{"id":831843,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:50.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":1467,"price":4.09,"value":6000.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":163994,"source":{"system":"sec-edgar","filing":"0001628280-26-020189","document":"wk-form4_1774038346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026020189/wk-form4_1774038346.xml","form_type":"4"}},{"id":831842,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:50.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":1138,"price":4.13,"value":4699.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":165461,"source":{"system":"sec-edgar","filing":"0001628280-26-020189","document":"wk-form4_1774038346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026020189/wk-form4_1774038346.xml","form_type":"4"}},{"id":832483,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:41.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":419,"price":4.12,"value":1726.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":110397,"source":{"system":"sec-edgar","filing":"0001628280-26-020188","document":"wk-form4_1774038338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026020188/wk-form4_1774038338.xml","form_type":"4"}},{"id":832482,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:41.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":1589,"price":4.09,"value":6499.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":110816,"source":{"system":"sec-edgar","filing":"0001628280-26-020188","document":"wk-form4_1774038338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026020188/wk-form4_1774038338.xml","form_type":"4"}},{"id":832481,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:41.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":1449,"price":4.13,"value":5984.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":112405,"source":{"system":"sec-edgar","filing":"0001628280-26-020188","document":"wk-form4_1774038338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026020188/wk-form4_1774038338.xml","form_type":"4"}},{"id":832272,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:26.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":15944,"price":3.85,"value":61384.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":752987,"source":{"system":"sec-edgar","filing":"0001628280-26-020186","document":"wk-form4_1774038323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026020186/wk-form4_1774038323.xml","form_type":"4"}},{"id":832271,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:26.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":4358,"price":4.13,"value":17998.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":768931,"source":{"system":"sec-edgar","filing":"0001628280-26-020186","document":"wk-form4_1774038323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026020186/wk-form4_1774038323.xml","form_type":"4"}},{"id":832490,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56863,"kind":"person","name":"Devlin Jodi","position":1,"cik":"0001992151","reported_name":"Devlin Jodi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Clinical Operations"}}],"security":"Common Stock","published_at":"2026-03-20T16:25:55.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":273,"price":4.12,"value":1124.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":97364,"source":{"system":"sec-edgar","filing":"0001628280-26-020190","document":"wk-form4_1774038352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1992151/000162828026020190/wk-form4_1774038352.xml","form_type":"4"}},{"id":832489,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56863,"kind":"person","name":"Devlin Jodi","position":1,"cik":"0001992151","reported_name":"Devlin Jodi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Clinical Operations"}}],"security":"Common Stock","published_at":"2026-03-20T16:25:55.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":1772,"price":4.09,"value":7247.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":97637,"source":{"system":"sec-edgar","filing":"0001628280-26-020190","document":"wk-form4_1774038352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1992151/000162828026020190/wk-form4_1774038352.xml","form_type":"4"}},{"id":832488,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56863,"kind":"person","name":"Devlin Jodi","position":1,"cik":"0001992151","reported_name":"Devlin Jodi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Clinical Operations"}}],"security":"Common Stock","published_at":"2026-03-20T16:25:55.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":1162,"price":4.13,"value":4799.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":99409,"source":{"system":"sec-edgar","filing":"0001628280-26-020190","document":"wk-form4_1774038352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1992151/000162828026020190/wk-form4_1774038352.xml","form_type":"4"}},{"id":832486,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-03-20T16:25:34.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":774,"price":4.12,"value":3188.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":124110,"source":{"system":"sec-edgar","filing":"0001628280-26-020187","document":"wk-form4_1774038332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000162828026020187/wk-form4_1774038332.xml","form_type":"4"}},{"id":832485,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-03-20T16:25:34.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":1552,"price":4.09,"value":6347.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":124884,"source":{"system":"sec-edgar","filing":"0001628280-26-020187","document":"wk-form4_1774038332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000162828026020187/wk-form4_1774038332.xml","form_type":"4"}},{"id":832484,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-03-20T16:25:34.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":1204,"price":4.13,"value":4972.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":126436,"source":{"system":"sec-edgar","filing":"0001628280-26-020187","document":"wk-form4_1774038332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000162828026020187/wk-form4_1774038332.xml","form_type":"4"}},{"id":887421,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-23T21:08:30.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":3657,"price":4.1,"value":14993.7,"ownership":{"direct":true},"balance_after":268657,"source":{"system":"sec-edgar","filing":"0001628280-26-010606","document":"wk-form4_1771880906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026010606/wk-form4_1771880906.xml","form_type":"4"}},{"id":888202,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46473,"kind":"person","name":"Gordon Gary B.","position":1,"cik":"0001811354","reported_name":"Gordon Gary B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:08:23.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":9756,"price":4.1,"value":39999.6,"ownership":{"direct":true},"balance_after":9756,"source":{"system":"sec-edgar","filing":"0001628280-26-010605","document":"wk-form4_1771880900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811354/000162828026010605/wk-form4_1771880900.xml","form_type":"4"}},{"id":888348,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46962,"kind":"person","name":"Valle William","position":1,"cik":"0002018493","reported_name":"Valle William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:08:15.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":30487,"price":4.1,"value":124996.7,"ownership":{"direct":true},"balance_after":30487,"source":{"system":"sec-edgar","filing":"0001628280-26-010604","document":"wk-form4_1771880892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018493/000162828026010604/wk-form4_1771880892.xml","form_type":"4"}},{"id":887896,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-02-23T21:08:06.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":30487,"price":4.1,"value":124996.7,"ownership":{"direct":true},"balance_after":773289,"source":{"system":"sec-edgar","filing":"0001628280-26-010603","document":"wk-form4_1771880883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000162828026010603/wk-form4_1771880883.xml","form_type":"4"}},{"id":887925,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:08:00.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":117198,"price":4.1,"value":480511.8,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities were purchased by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member."}],"balance_after":199698,"source":{"system":"sec-edgar","filing":"0001628280-26-010602","document":"wk-form4_1771880877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026010602/wk-form4_1771880877.xml","form_type":"4"}},{"id":887924,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:08:00.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":243900,"price":4.1,"value":999990.0,"ownership":{"direct":true},"balance_after":787132,"source":{"system":"sec-edgar","filing":"0001628280-26-010602","document":"wk-form4_1771880877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026010602/wk-form4_1771880877.xml","form_type":"4"}},{"id":909818,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46414,"kind":"person","name":"Stansky Michael P","position":1,"cik":"0001424204","reported_name":"Stansky Michael P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-02-11T23:51:12.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":92537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option vest in three equal annual installments commencing on February 4, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":92537,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":92537},"source":{"system":"sec-edgar","filing":"0001628280-26-007409","document":"wk-form4_1770853869.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424204/000162828026007409/wk-form4_1770853869.xml","form_type":"4"}},{"id":988301,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T21:15:56.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":261954,"derivative":{"exercise_price":5.55,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001981787-25-000004","document":"wk-form4_1764105353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000198178725000004/wk-form4_1764105353.xml","form_type":"4"}},{"id":988300,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Common Stock","published_at":"2025-11-25T21:15:56.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":166599,"source":{"system":"sec-edgar","filing":"0001981787-25-000004","document":"wk-form4_1764105353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000198178725000004/wk-form4_1764105353.xml","form_type":"4"}},{"id":988560,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T20:55:07.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares\nshall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":1578182,"derivative":{"exercise_price":5.55,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001410289-25-000006","document":"wk-form4_1764104104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000141028925000006/wk-form4_1764104104.xml","form_type":"4"}},{"id":988559,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-11-25T20:55:07.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the granting of PSUs upon achieving or exceeding $75 million of revenue over any 12 consecutive calendar month period ending on or before December 31, 2027. 150,000 PSUs vest immediately upon achieving the performance requirement and 150,000 PSUs vest on the one-year anniversary of achieving the performance requirement, subject to the continued employment through each respective vesting date."}],"balance_after":742802,"source":{"system":"sec-edgar","filing":"0001410289-25-000006","document":"wk-form4_1764104104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000141028925000006/wk-form4_1764104104.xml","form_type":"4"}},{"id":988558,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-11-25T20:55:07.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":442802,"source":{"system":"sec-edgar","filing":"0001410289-25-000006","document":"wk-form4_1764104104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000141028925000006/wk-form4_1764104104.xml","form_type":"4"}},{"id":988557,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-11-25T20:55:07.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the granting of Performance Stock Units (PSUs) upon achieving or exceeding $50 million of revenue over any 12 consecutive calendar month period ending on or before February 28, 2027. The PSUs vest immediately upon achieving the performance requirement, subject to the continued employment through each respective vesting date."}],"balance_after":317802,"source":{"system":"sec-edgar","filing":"0001410289-25-000006","document":"wk-form4_1764104104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410289/000141028925000006/wk-form4_1764104104.xml","form_type":"4"}},{"id":988873,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T20:42:15.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":408937,"derivative":{"exercise_price":5.55,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001982638-25-000004","document":"wk-form4_1764103333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000198263825000004/wk-form4_1764103333.xml","form_type":"4"}},{"id":988872,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-25T20:42:15.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":113854,"source":{"system":"sec-edgar","filing":"0001982638-25-000004","document":"wk-form4_1764103333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000198263825000004/wk-form4_1764103333.xml","form_type":"4"}},{"id":988299,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T20:40:45.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":668899,"derivative":{"exercise_price":5.55,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001970009-25-000004","document":"wk-form4_1764103242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000197000925000004/wk-form4_1764103242.xml","form_type":"4"}},{"id":988298,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-25T20:40:45.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":265000,"source":{"system":"sec-edgar","filing":"0001970009-25-000004","document":"wk-form4_1764103242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000197000925000004/wk-form4_1764103242.xml","form_type":"4"}},{"id":988903,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56863,"kind":"person","name":"Devlin Jodi","position":1,"cik":"0001992151","reported_name":"Devlin Jodi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Clinical Operations"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T15:56:02.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":463750,"derivative":{"exercise_price":5.55,"expiration_date":"2025-11-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001992151-25-000004","document":"wk-form4_1764104159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1992151/000199215125000004/wk-form4_1764104159.xml","form_type":"4"}},{"id":988902,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56863,"kind":"person","name":"Devlin Jodi","position":1,"cik":"0001992151","reported_name":"Devlin Jodi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Clinical Operations"}}],"security":"Common Stock","published_at":"2025-11-25T15:56:02.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":100571,"source":{"system":"sec-edgar","filing":"0001992151-25-000004","document":"wk-form4_1764104159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1992151/000199215125000004/wk-form4_1764104159.xml","form_type":"4"}},{"id":988876,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T15:43:38.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":323782,"derivative":{"exercise_price":5.55,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001982621-25-000009","document":"wk-form4_1764103415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000198262125000009/wk-form4_1764103415.xml","form_type":"4"}},{"id":988875,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-11-25T15:43:38.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":127640,"source":{"system":"sec-edgar","filing":"0001982621-25-000009","document":"wk-form4_1764103415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000198262125000009/wk-form4_1764103415.xml","form_type":"4"}},{"id":1052550,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-29T20:18:12.000Z","date":"2025-08-28","kind":"grant","planned":false,"acquired":true,"shares":248899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the granting of stock options upon achieving or exceeding $75 million of revenue over any twelve (12) consecutive calendar month period ending on or before December 31, 2027. The options vest immediately upon achieving the performance requirement, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock options expire on December 31, 2027 if the revenue threshold is not met."}],"balance_after":538899,"derivative":{"exercise_price":5.11,"underlying":"Common Stock","underlying_shares":248899},"source":{"system":"sec-edgar","filing":"0001826667-25-000131","document":"wk-form4_1756498688.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000131/wk-form4_1756498688.xml","form_type":"4"}},{"id":1064947,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-15T21:29:18.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of July 1, 2026 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":290000,"derivative":{"exercise_price":3.88,"expiration_date":"2035-08-13","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001826667-25-000121","document":"wk-form4_1755293353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000121/wk-form4_1755293353.xml","form_type":"4"}},{"id":1064946,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T21:29:18.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on July 1, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001826667-25-000121","document":"wk-form4_1755293353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000121/wk-form4_1755293353.xml","form_type":"4"}},{"id":1099859,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":20726,"kind":"person","name":"Desai Arjun JJ","position":1,"cik":"0001982985","reported_name":"Desai Arjun JJ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T20:29:54.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":65000,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000091","document":"wk-form4_1751056186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000091/wk-form4_1751056186.xml","form_type":"4"}},{"id":1100328,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46473,"kind":"person","name":"Gordon Gary B.","position":1,"cik":"0001811354","reported_name":"Gordon Gary B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T20:26:56.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":56250,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000089","document":"wk-form4_1751056010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811354/000182666725000089/wk-form4_1751056010.xml","form_type":"4"}},{"id":1100537,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":47004,"kind":"person","name":"HICKS KERRY R","position":1,"cik":"0001110473","reported_name":"HICKS KERRY R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T20:22:53.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":89222,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000087","document":"wk-form4_1751055766.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110473/000182666725000087/wk-form4_1751055766.xml","form_type":"4"}},{"id":1100099,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T20:20:53.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":65000,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000085","document":"wk-form4_1751055648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000182666725000085/wk-form4_1751055648.xml","form_type":"4"}},{"id":1100481,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":46962,"kind":"person","name":"Valle William","position":1,"cik":"0002018493","reported_name":"Valle William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T20:16:14.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":56250,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000081","document":"wk-form4_1751055368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018493/000182666725000081/wk-form4_1751055368.xml","form_type":"4"}},{"id":1100139,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T20:12:27.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":200945,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000079","document":"wk-form4_1751055139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000182666725000079/wk-form4_1751055139.xml","form_type":"4"}},{"id":1100242,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":78045,"kind":"person","name":"Murphy Sean","position":1,"cik":"0001685042","reported_name":"Murphy Sean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T16:18:21.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":554681,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000083","document":"wk-form4_1751055493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685042/000182666725000083/wk-form4_1751055493.xml","form_type":"4"}},{"id":1138589,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Common Stock","published_at":"2025-05-21T21:33:13.000Z","date":"2025-05-19","kind":"sale","planned":false,"acquired":false,"shares":4764,"price":5.18,"value":24677.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of the shares was to cover the tax liability associated with the granted RSUs."}],"balance_after":119415,"source":{"system":"sec-edgar","filing":"0001826667-25-000061","document":"wk-form4_1747863185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000061/wk-form4_1747863185.xml","form_type":"4"}},{"id":1138588,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Research"}}],"security":"Common Stock","published_at":"2025-05-21T21:33:13.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":15722,"price":5.18,"value":81439.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The granted RSUs vest immediately."}],"balance_after":124179,"source":{"system":"sec-edgar","filing":"0001826667-25-000061","document":"wk-form4_1747863185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000061/wk-form4_1747863185.xml","form_type":"4"}},{"id":1139198,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:30:33.000Z","date":"2025-05-19","kind":"sale","planned":false,"acquired":false,"shares":6597,"price":5.18,"value":34172.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of the shares was to cover the tax liability associated with the granted RSUs."}],"balance_after":69101,"source":{"system":"sec-edgar","filing":"0001826667-25-000057","document":"wk-form4_1747863026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000182666725000057/wk-form4_1747863026.xml","form_type":"4"}},{"id":1139197,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:30:33.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":21428,"price":5.18,"value":110997.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The granted RSUs vest immediately."}],"balance_after":75698,"source":{"system":"sec-edgar","filing":"0001826667-25-000057","document":"wk-form4_1747863026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000182666725000057/wk-form4_1747863026.xml","form_type":"4"}},{"id":1139239,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":79485,"kind":"person","name":"Young James Emmett","position":1,"cik":"0002050748","reported_name":"Young James Emmett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T17:37:01.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":13175,"price":5.18,"value":68246.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The granted RSUs vest immediately."}],"balance_after":49663,"source":{"system":"sec-edgar","filing":"0001826667-25-000063","document":"wk-form4_1747863414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050748/000182666725000063/wk-form4_1747863414.xml","form_type":"4"}},{"id":1139202,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56863,"kind":"person","name":"Devlin Jodi","position":1,"cik":"0001992151","reported_name":"Devlin Jodi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Clinical Operations"}}],"security":"Common Stock","published_at":"2025-05-21T17:31:57.000Z","date":"2025-05-19","kind":"sale","planned":false,"acquired":false,"shares":4764,"price":5.18,"value":24677.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of the shares was to cover the tax liability associated with the granted RSUs."}],"balance_after":52764,"source":{"system":"sec-edgar","filing":"0001826667-25-000059","document":"wk-form4_1747863107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1992151/000182666725000059/wk-form4_1747863107.xml","form_type":"4"}},{"id":1139201,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56863,"kind":"person","name":"Devlin Jodi","position":1,"cik":"0001992151","reported_name":"Devlin Jodi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief of Clinical Operations"}}],"security":"Common Stock","published_at":"2025-05-21T17:31:57.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":24131,"price":5.18,"value":124998.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The granted RSUs vest immediately."}],"balance_after":57528,"source":{"system":"sec-edgar","filing":"0001826667-25-000059","document":"wk-form4_1747863107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1992151/000182666725000059/wk-form4_1747863107.xml","form_type":"4"}},{"id":1139023,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":78045,"kind":"person","name":"Murphy Sean","position":1,"cik":"0001685042","reported_name":"Murphy Sean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T17:28:57.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":44884,"price":5.18,"value":232499.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The granted RSUs vest immediately."}],"balance_after":123989,"source":{"system":"sec-edgar","filing":"0001826667-25-000055","document":"wk-form4_1747862929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685042/000182666725000055/wk-form4_1747862929.xml","form_type":"4"}},{"id":1139200,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-05-21T17:27:29.000Z","date":"2025-05-19","kind":"sale","planned":false,"acquired":false,"shares":8704,"price":5.18,"value":45086.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of the shares was to cover the tax liability associated with the granted RSUs."}],"balance_after":77640,"source":{"system":"sec-edgar","filing":"0001826667-25-000053","document":"wk-form4_1747862841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000182666725000053/wk-form4_1747862841.xml","form_type":"4"}},{"id":1139199,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56861,"kind":"person","name":"Stevens Jennifer","position":1,"cik":"0001982621","reported_name":"Stevens Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-05-21T17:27:29.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":28455,"price":5.18,"value":147396.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The granted RSUs vest immediately."}],"balance_after":86344,"source":{"system":"sec-edgar","filing":"0001826667-25-000053","document":"wk-form4_1747862841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982621/000182666725000053/wk-form4_1747862841.xml","form_type":"4"}},{"id":1258407,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":56776,"kind":"person","name":"Cox Bryan F.","position":1,"cik":"0001981787","reported_name":"Cox Bryan F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OF RESEARCH"}}],"security":"Common Stock","published_at":"2025-02-19T22:45:09.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":11450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":108457,"source":{"system":"sec-edgar","filing":"0001415889-25-004685","document":"form4-02192025_100205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000141588925004685/form4-02192025_100205.xml","form_type":"4"}}],"next_cursor":"2025-02-19T22:45:09.000000Z,1258407"}